In some instances, however, tumors can preserve high levels of protective HLA-I, as occurs in hematological malignancies [41], or upregulate HLA-I as an adaptive mechanism to the IFN-γ and TNF-α mediators released by cytotoxic cells during tumor aggression [35,42]. This evidence concerns the gene IFNG and neoplasm.